Last update:

Medications news

Medications

Critical heart drug too pricey for some Medicare patients

An effective drug to treat chronic heart failure may cost too much for senior citizens with a standard Medicare Part D drug plan, said a study co-authored by a John A. Burns School of Medicine (JABSOM) researcher at the University ...

Medications
Medications

Old vaccine brings new surprises

New research about an old vaccine—one that has been in use for nearly 100 years—has not only shown how effective it is but also suggests it improves our immune response to a wider range of bacteria than originally intended.

Medications

Hospitals put Native Americans at opioid risk, audit says

U.S. government hospitals placed Native American patients at increased risk for opioid abuse and overdoses, failing to follow their own protocols for prescribing and dispensing the drugs, according to a federal audit made ...

Medications

Q&A: Newly public data maps opioid crisis across US

The release of a massive trove of data from lawsuits over the nation's opioid crisis provides the most detailed accounting to date of the role played by the major pharmaceutical companies and distributors.

Medications

Supply of opioids predicts long-term use in injured workers

(HealthDay)—The number of days supplied of an initial opioid prescription is the strongest risk factor for developing long-term opioid use among previously opioid-free injured workers, according to a study published online ...

Medications

Drug company, 4 people indicted in US painkiller probe

Federal authorities said Thursday an Ohio-based wholesale drug distributor that's been linked before to the opioid drug crisis has been charged in a painkiller pill distribution conspiracy case.

Medications

Some pharmacists missing mark on therapeutic guidelines:

As the role of pharmacies in providing front-line public health services grows, a QUT study has raised concerns that some are not adhering to therapeutic guidelines when distributing pharmaceuticals.

Medications

Data shows flood of opioids across US, many of them generics

The maker of OxyContin has been cast as the chief villain in the nation's opioid crisis. But newly released government figures suggest Purdue Pharma had plenty of help in flooding the U.S. with billions of pills even as overdose ...